Valuation: Terumo Corporation

Market Cap 3,376B 20.63B 18.1B 16.86B 15.5B 29.06B 1,971B 29.56B 200B 78.27B 977B 77.44B 75.76B P/E 2027 *
20.2x
P/E 2028 * 18.2x
Enterprise Value 3,452B 21.09B 18.51B 17.24B 15.85B 29.72B 2,015B 30.23B 204B 80.04B 999B 79.18B 77.47B EV / Sales 2027 *
2.79x
EV / Sales 2028 * 2.58x
Free-Float
97.07%
Yield 2027 *
1.56%
Yield 2028 * 1.74%
1 day+1.78%
1 week+0.95%
Current month+2.46%
1 month+3.48%
3 months+13.04%
6 months+9.97%
Current year+0.84%
1 week 2,133
Extreme 2133
2,330.5
1 month 2,133
Extreme 2133
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.78%+0.95%-11.55%+0.68% 20.27B
+2.93%+7.56%-15.15%-4.90% 182B
+3.36%+5.44%-5.59%-1.61% 108B
+0.22%+5.59%+11.82%+71.54% 60.54B
-4.21%-6.07%+22.50%+49.01% 50.53B
+6.90%+7.90%-9.27%-40.79% 43.79B
+0.82%+3.68% - - 33.57B
+2.87%+0.64%-15.97%-43.17% 28.31B
-1.18%-5.92%+31.12%-7.52% 23.31B
+14.89%+8.47%+1.39%-0.15% 21.28B
Average +2.33%-0.63%+1.03%+2.57% 57.14B
Weighted average by Cap. +2.44%+0.72%-3.43%+4.78%

Financials

2027 *2028 *
Net sales 1,239B 7.57B 6.64B 6.18B 5.69B 10.66B 723B 10.85B 73.38B 28.72B 359B 28.41B 27.8B 1,318B 8.05B 7.06B 6.58B 6.05B 11.34B 769B 11.54B 78.04B 30.55B 381B 30.22B 29.57B
Net income 166B 1.01B 888M 827M 761M 1.43B 96.72B 1.45B 9.82B 3.84B 47.97B 3.8B 3.72B 185B 1.13B 993M 925M 850M 1.59B 108B 1.62B 10.97B 4.29B 53.61B 4.25B 4.16B
Net Debt 75.98B 464M 407M 379M 349M 654M 44.35B 665M 4.5B 1.76B 21.99B 1.74B 1.7B 16.78B 103M 89.97M 83.78M 77.06M 144M 9.79B 147M 994M 389M 4.86B 385M 377M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
28/07/26 ¥2,289.00 +1.78% 5,281,100
27/07/26 ¥2,249.00 +3.90% 4,788,800
24/07/26 ¥2,164.50 +0.30% 2,693,400
23/07/26 ¥2,158.00 -1.86% 3,500,500
22/07/26 ¥2,199.00 -1.85% 4,119,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,289.00JPY
Average target price
2,961.54JPY
Spread / Average Target
+29.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock